[Treatment of patients with diabetes and diabetic angiopathies of the lower extremities with butylbiguanide (Silubin retard)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001645:Biguanides / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005734:Gangrene / Q000188:drug therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D009765:Obesity; D012008:Recurrence
D000900:Anti-Bacterial Agents; D001645:Biguanides; D005938:Glucocorticoids; D007004:Hypoglycemic Agents; D007328:Insulin
O lechenii bol'nykh diabetom i diabeticheskoĭ angiopatieĭ nizhnikh konechnosteĭ butilbiguanidom (Silubin retard)